Graph AI, a California-based AI life sciences company focused on patient safety and pharmacovigilance, has raised $3 million in seed funding, led by Bessemer Venture Partners (BVP). The investment will enable Graph AI to accelerate product innovation, expand its engineering team, and drive global market adoption.
Graph AI is part of a new generation of AI-native challengers reshaping the pharma and life sciences industry, with a sharp focus on the $8 billion pharmacovigilance market. Pharmacovigilance, mandated by global drug regulators, requires pharmaceutical companies to monitor, detect, and report adverse drug events (ADEs) across a drug’s entire lifecycle — from clinical trials to post-market use — ensuring patient safety and compliance.
Traditionally, pharmaceutical firms have depended on large service providers to manually extract and process data from unstructured sources such as call centre transcripts, legal filings, medical literature, emails, and social media. These processes involve vast teams of pharmacology graduates manually reviewing thousands of documents to assess ADE causality, submit regulatory reports, and recommend follow-up actions — often leading to slow, fragmented, and error-prone workflows.
The company’s flagship platform, Graph Safety, redefines pharmacovigilance by combining context-aware artificial intelligence and intelligent automation to deliver a complete, end-to-end safety solution. Already deployed with enterprise customers, Graph Safety automates processes such as ADE case management, signal detection, aggregate reporting, and regulatory compliance, while continuously building a centralised safety intelligence database.
By retaining a human-in-the-loop only for select regulatory-mandated steps, Graph enables pharmaceutical companies to transition from manual, reactive workflows to AI-driven, proactive systems, significantly improving efficiency, accuracy, and compliance across safety operations.
Founded in 2024, Graph AI is led by Raghav Parvataraju (CEO), Vijay Ponukumati (CTO), Mohan Konyala (CPO), and Ashutosh Bordekar (CFO), seasoned professionals with experience at LTI Mindtree, Infosys, ServiceNow, Google, and Cisco. Their collective expertise in technology, outsourcing, and enterprise operations has been pivotal in shaping Graph’s mission to transform pharmacovigilance through AI innovation.
In just over a year, Graph AI has achieved strong traction and tangible results. Its proprietary AI models demonstrate high accuracy, ensuring consistent classification and complete data extraction from both structured and unstructured sources. Enterprise clients have reported up to 70% efficiency gains, 90% faster regulatory reporting, and substantial cost reductions, while maintaining full traceability and audit readiness. The company’s platform now supports a pipeline covering over 7,000 marketed drugs, underscoring growing demand for modernised pharmacovigilance solutions.
In a joint statement, the founders said:
“The life sciences industry continues to grapple with outdated technology, fragmented point solutions, data silos, and manual handoffs that hinder decision-making and elevate compliance risks. At Graph AI, we’re addressing these challenges with a unified, AI-native safety platform that integrates context, compliance, and intelligence into a single seamless ecosystem. Our vision is to make patient safety smarter, faster, and more connected, empowering pharmaceutical and biotech enterprises to achieve safer outcomes, stronger regulatory confidence, and exponential efficiency across safety operations.”
Nithin Kaimal, Partner and COO at Bessemer Venture Partners India, added, “We’re excited to partner with Graph AI as they redefine labour intensive and inefficient pharmacovigilance workflows through AI-native solutions that prioritise both accuracy and scalability. At Bessemer, we’re deeply optimistic about the transformative potential of AI products to reimagine traditional services models as for the first time, delivery is shifting from labour arbitrage to intelligence arbitrage, empowering enterprises to work with firms that deliver faster, smarter, and more adaptive solutions. We look forward to supporting the Graph team as they continue to scale new heights.”
Leave a Reply